Diagnostic value of antibodies against a modified citrullinated vimentin, cyclic citrullinated peptide and IgM rheumatoid factor in early rheumatoid arthritis

被引:0
|
作者
Novikov, A. A. [1 ]
Alexandrova, E. N. [1 ]
Karateev, D. E. [1 ]
Demidova, N. V. [1 ]
Cherkasova, M. V. [1 ]
Denisov, L. N. [1 ]
Nasonov, E. L. [1 ]
机构
[1] State Inst Rheumatol, Moscow, Russia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:333 / 333
页数:1
相关论文
共 50 条
  • [41] Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in the diagnosis of early versus established rheumatoid arthritis
    Kyriazis, NC
    Papalopoulou, M
    Balla, M
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 172 - 172
  • [42] DIAGNOSTIC VALUE OF ANTI MUTATED CITRULLINATED VIMENTIN IN COMPARISON TO ANTI-CYCLIC CITRULLINATED PEPTIDE AND ANTI-VIRAL CITRULLINATED PEPTIDE 2 ANTIBODIES IN RHEUMATOID ARTHRITIS: A MULTICENTRIC STUDY BY FIRMA GROUP
    Bartoloni, E.
    Alunno, A.
    Bistoni, O.
    Bizzaro, N.
    Morozzi, G.
    Doria, A.
    Mathieu, A.
    Lotzniker, M.
    Allegri, F.
    Riccieri, V.
    Alpini, C.
    Gabrielli, A.
    Tampoia, M.
    Gerli, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 607 - 607
  • [43] Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis
    Chang, Pi-Yueh
    Yang, Cheng-Tao
    Cheng, Ching-Hui
    Yu, Kuang-Hui
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (09) : 880 - 886
  • [44] Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides
    Innala, Lena
    Kokkonen, Heidi
    Eriksson, Catharina
    Jidell, Erik
    Berglin, Ewa
    Rantapaa-Dahlqvist, Solbritt
    [J]. JOURNAL OF RHEUMATOLOGY, 2008, 35 (06) : 1002 - 1008
  • [45] A Comparison Between IgG- and IgA-class Antibodies to Cyclic Citrullinated Peptides and to Modified Citrullinated Vimentin in Early Rheumatoid Arthritis and Very Early Arthritis
    Svard, Anna
    Kastbom, Alf
    Soderlin, Maria K.
    Reckner-Olsson, Asa
    Skogh, Thomas
    [J]. JOURNAL OF RHEUMATOLOGY, 2011, 38 (07) : 1265 - 1272
  • [46] Value of Anti-Modified Citrullinated Vimentin and Third-Generation Anti-Cyclic Citrullinated Peptide Compared With Second-Generation Anti-Cyclic Citrullinated Peptide and Rheumatoid Factor in Predicting Disease Outcome in Undifferentiated Arthritis and Rheumatoid Arthritis
    van der Linden, Michael P. M.
    van der Woude, Diane
    Ioan-Facsinay, Andreea
    Levarht, E. W. Nivine
    Stoeken-Rijsbergen, Gerrie
    Huizinga, Tom W. J.
    Toes, Rene E. M.
    van der Helm-van Mil, Annette H. M.
    [J]. ARTHRITIS AND RHEUMATISM, 2009, 60 (08): : 2232 - 2241
  • [47] Differentiation of Rheumatoid Arthritis From HCV Infection: Rheumatoid Factor, Anti-Cyclic Citrullinated Peptide or Anti-Mutated Citrullinated Vimentin?
    Kaptanoglu, Ece
    Nadir, Isilay
    Bakici, Zahir
    Hayta, Emrullah
    Turkmen, Mehmet
    Sezer, Hafize
    Hizmetli, Sami
    Elden, Hasan
    [J]. TURKISH JOURNAL OF RHEUMATOLOGY, 2010, 25 (01) : 19 - 23
  • [48] Discriminative and diagnostic value of anti-cyclic citrullinated peptide antibodies in Iranian patients with rheumatoid arthritis
    Jamileh Moghimi
    Raheb Ghorbani
    Farnaz Hasani
    Mehrdad Sheikhvatan
    [J]. Rheumatology International, 2013, 33 : 601 - 605
  • [49] Discriminative and diagnostic value of anti-cyclic citrullinated peptide antibodies in Iranian patients with rheumatoid arthritis
    Moghimi, Jamileh
    Ghorbani, Raheb
    Hasani, Farnaz
    Sheikhvatan, Mehrdad
    [J]. RHEUMATOLOGY INTERNATIONAL, 2013, 33 (03) : 601 - 605
  • [50] Diagnostic value of anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis treated with etanercept
    Drynda, S.
    Wollenberg, H.
    Khne, C.
    Polter, J.
    Kekow, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : A21 - A22